These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 9095332)

  • 1. Granulocyte macrophage colony stimulating factor pretreatment induces an increase of rat Kupffer cells with enhanced cytotoxicity in vitro and prevention of tumor outgrowth in vivo.
    Schuurman B; Koenen HJ; Beelen RH; Meyer S
    Anticancer Drugs; 1997 Mar; 8(3):269-75. PubMed ID: 9095332
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of intraperitoneally administered recombinant murine granulocyte-macrophage colony-stimulating factor (rmGM-CSF) on the cytotoxic potential of murine peritoneal cells.
    Klimp AH; Regts J; Scherphof GL; de Vries EG; Daemen T
    Br J Cancer; 1999 Jan; 79(1):89-94. PubMed ID: 10408698
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human recombinant macrophage colony stimulating factor activates murine Kupffer cells to a cytotoxic state.
    Curley SA; Roh MS; Kleinerman E; Klostergaard J
    Lymphokine Res; 1990; 9(3):355-63. PubMed ID: 2118971
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhanced killing capacity of human Kupffer cells after activation with human granulocyte/macrophage-colony-stimulating factor and interferon gamma.
    Schuurman B; Heuff G; Beelen RH; Meyer S
    Cancer Immunol Immunother; 1994 Sep; 39(3):179-84. PubMed ID: 7923248
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Granulocyte colony-stimulating factor (G-CSF) reduces not only gram-negative but also gram-positive infection-associated proinflammatory cytokine release by interaction between Kupffer cells and leukocytes.
    Busch CJ; Wanner GA; Menger MD; Vollmar B
    Inflamm Res; 2004 May; 53(5):205-10. PubMed ID: 15105970
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modulation of neonatal myelopoiesis in newborn rats after 7 days' administration of either granulocyte-monocyte colony stimulating factor or interleukin-3.
    Cairo MS; Mauss D; Plunkett JM; Gillis S; van de Ven C
    Pediatr Res; 1991 May; 29(5):504-9. PubMed ID: 1896256
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhancement of in vitro and in vivo anti-tumor activity of anti-GD2 monoclonal antibody 220-51 against human neuroblastoma by granulocyte-macrophage colony-stimulating factor and granulocyte colony-stimulating factor.
    Fukuda M; Horibe K; Furukawa K
    Int J Mol Med; 1998 Oct; 2(4):471-5. PubMed ID: 9857237
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diphtheria toxin-murine granulocyte-macrophage colony-stimulating factor-induced hepatotoxicity is mediated by Kupffer cells.
    Westcott MM; Abi-Habib RJ; Cohen KA; Willingham MC; Liu S; Bugge TH; Leppla SH; Frankel AE
    Mol Cancer Ther; 2004 Dec; 3(12):1681-9. PubMed ID: 15634662
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The combination 5-fluorouracil/levamisole induces enhanced rat Kupffer cell-mediated cytotoxicity in vitro against the syngeneic colon adenocarcinoma cell line CC531.
    Schuurman B; Sirovich I; Heuff G; van der Wilt CL; Peters GJ; Beelen RH; Meyer S
    J Surg Oncol; 1995 Nov; 60(3):180-4. PubMed ID: 7475068
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhanced antitumor effect of recombinant human tumor necrosis factor in combination with recombinant human granulocyte colony-stimulating factor in BALB/c mice.
    Maeda M; Watanabe N; Tsuji N; Tsuji Y; Okamoto T; Sasaki H; Akiyama S; Niitsu Y
    Jpn J Cancer Res; 1993 Aug; 84(8):921-7. PubMed ID: 7691787
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reduction of the leukemogenic potential of malignant murine leukemic cells by in vivo treatment with recombinant human granulocyte colony-stimulating factor.
    Tamura M; Orita T; Oh-eda M; Hasegawa M; Nomura H; Maekawa T; Abe T; Ono M
    Leuk Res; 1993 Jul; 17(7):593-600. PubMed ID: 7686992
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Granulocyte colony-stimulating factor treatment protects rodents against lipopolysaccharide-induced toxicity via suppression of systemic tumor necrosis factor-alpha.
    Görgen I; Hartung T; Leist M; Niehörster M; Tiegs G; Uhlig S; Weitzel F; Wendel A
    J Immunol; 1992 Aug; 149(3):918-24. PubMed ID: 1378868
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Action of granulopoiesis-stimulating cytokines rhG-CSF, rhGM-CSF, and rmGM-CSF on murine haematopoietic progenitor cells for granulocytes and macrophages (GM-CFC).
    Hofer M; Vacek A; Weiterová L
    Physiol Res; 2005; 54(2):207-13. PubMed ID: 15544422
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of macrophage colony-stimulating factor in the differentiation and proliferation of Kupffer cells in the liver of protein-deprived mice.
    Honda Y; Takahashi K; Naito M; Fujiyama S
    Lab Invest; 1995 Jun; 72(6):696-706. PubMed ID: 7783428
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of recombinant human macrophage colony-stimulating factor on proliferation, differentiation and survival of Kupffer cells in the liver of adult mice.
    Miyakawa K; Myint YY; Takahashi K
    Anal Quant Cytol Histol; 1999 Aug; 21(4):329-35. PubMed ID: 10560510
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor necrosis factor production by rat Kupffer cells-regulation by lipopolysaccharide, macrophage activating factor and prostaglandin E2.
    Tanaka M; Ishibashi H; Hirata Y; Miki K; Kudo J; Niho Y
    J Clin Lab Immunol; 1996; 48(1):17-31. PubMed ID: 10332631
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunomodulatory action of G-CSF in a rat model of endotoxin-induced liver injury: an intravital microscopic analysis of Kupffer cell and leukocyte response.
    Vollmar B; Messner S; Wanner GA; Hartung T; Menger MD
    J Leukoc Biol; 1997 Dec; 62(6):710-8. PubMed ID: 9400811
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Isolation of cytotoxic Kupffer cells by a modified enzymatic assay: a methodological study.
    Heuff G; Steenbergen JJ; Van de Loosdrecht AA; Sirovich I; Dijkstra CD; Meyer S; Beelen RH
    J Immunol Methods; 1993 Feb; 159(1-2):115-23. PubMed ID: 8445244
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Continuous intravenous administration of rmGM-CSF enhances immune as well as hematopoietic reconstitution following syngeneic bone marrow transplantation in mice.
    Naparstek E; Ohana M; Greenberger JS; Slavin S
    Exp Hematol; 1993 Jan; 21(1):131-7. PubMed ID: 8417949
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of recombinant human granulocyte colony-stimulating factor administration in normal and experimentally infected newborn rats.
    Iguchi K; Inoue S; Kumar A
    Exp Hematol; 1991 Jun; 19(5):352-8. PubMed ID: 1709109
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.